Search Results

Abacavir 50 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir

Abacavir 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir

Abacavir 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir

Apremilast 25 mg  | ≥98%

LKT Laboratories, Inc.

PDE4 inhibitor.

More Information Supplier Page

×

Apremilast

Apremilast 5 mg  | ≥98%

LKT Laboratories, Inc.

PDE4 inhibitor.

More Information Supplier Page

×

Apremilast

Emtricitabine 50 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (cytidine) analog; RT and telomerase inhibitor.

More Information Supplier Page

×

Emtricitabine

Regadenoson 100 mg  | ≥98%

LKT Laboratories, Inc.

Adenosine A2A agonist.

More Information Supplier Page

×

Regadenoson

Regadenoson 25 mg  | ≥98%

LKT Laboratories, Inc.

Adenosine A2A agonist.

More Information Supplier Page

×

Regadenoson

Regadenoson 5 mg  | ≥98%

LKT Laboratories, Inc.

Adenosine A2A agonist.

More Information Supplier Page

×

Regadenoson

Deracoxib 100 mg  | ≥98%

LKT Laboratories, Inc.

NSAID; COX-2 inhibitor.

More Information Supplier Page

×

Deracoxib